319 related articles for article (PubMed ID: 15019493)
1. Inflammatory effects of snake venom myotoxic phospholipases A2.
Teixeira CF; Landucci EC; Antunes E; Chacur M; Cury Y
Toxicon; 2003 Dec; 42(8):947-62. PubMed ID: 15019493
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity.
Gutiérrez JM; Ownby CL
Toxicon; 2003 Dec; 42(8):915-31. PubMed ID: 15019491
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a phospholipase A
Salvador GH; Dos Santos JI; Lomonte B; Fontes MR
Biochimie; 2017 Feb; 133():95-102. PubMed ID: 28034717
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro.
Lomonte B; Angulo Y; Rufini S; Cho W; Giglio JR; Ohno M; Daniele JJ; Geoghegan P; Gutiérrez JM
Toxicon; 1999 Jan; 37(1):145-58. PubMed ID: 9920486
[TBL] [Abstract][Full Text] [Related]
5. Natural phospholipase A(2) myotoxin inhibitor proteins from snakes, mammals and plants.
Lizano S; Domont G; Perales J
Toxicon; 2003 Dec; 42(8):963-77. PubMed ID: 15019494
[TBL] [Abstract][Full Text] [Related]
6. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction.
Ticli FK; Hage LI; Cambraia RS; Pereira PS; Magro AJ; Fontes MR; Stábeli RG; Giglio JR; França SC; Soares AM; Sampaio SV
Toxicon; 2005 Sep; 46(3):318-27. PubMed ID: 15992846
[TBL] [Abstract][Full Text] [Related]
7. A structure based model for liposome disruption and the role of catalytic activity in myotoxic phospholipase A2s.
Murakami MT; Arni RK
Toxicon; 2003 Dec; 42(8):903-13. PubMed ID: 15019490
[TBL] [Abstract][Full Text] [Related]
8. Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties.
Soares AM; Giglio JR
Toxicon; 2003 Dec; 42(8):855-68. PubMed ID: 15019487
[TBL] [Abstract][Full Text] [Related]
9. Phospholipases A2 from viperidae snake venoms: how do they induce skeletal muscle damage?
Lomonte B; Gutiérrez JM
Acta Chim Slov; 2011 Dec; 58(4):647-59. PubMed ID: 24061112
[TBL] [Abstract][Full Text] [Related]
10. Amino acid sequence of a basic aspartate-49-phospholipase A2 from Trimeresurus flavoviridis venom and phylogenetic analysis of Crotalinae venom phospholipases A2.
Chijiwa T; Abe K; Ogawa T; Nikandrov NN; Hattori S; Oda-Ueda N; Ohno M
Toxicon; 2005 Aug; 46(2):185-95. PubMed ID: 15972222
[TBL] [Abstract][Full Text] [Related]
11. Myotoxic and cytolytic activities of dimeric Lys49 phospholipase A2 homologues are reduced, but not abolished, by a pH-induced dissociation.
Angulo Y; Gutiérrez JM; Soares AM; Cho W; Lomonte B
Toxicon; 2005 Sep; 46(3):291-6. PubMed ID: 15970303
[TBL] [Abstract][Full Text] [Related]
12. Heterologous expression and biochemical and functional characterization of a recombinant alpha-type myotoxin inhibitor from Bothrops alternatus snake.
Santos-Filho NA; Boldrini-França J; Santos-Silva LK; Menaldo DL; Henrique-Silva F; Sousa TS; Cintra AC; Mamede CC; Oliveira F; Arantes EC; Antunes LM; Cilli EM; Sampaio SV
Biochimie; 2014 Oct; 105():119-28. PubMed ID: 25047442
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase A
Jia Y; Ermolinsky B; Garza A; Provenzano D
Toxicon; 2017 Sep; 135():84-92. PubMed ID: 28633930
[TBL] [Abstract][Full Text] [Related]
14. Structural bases for a complete myotoxic mechanism: crystal structures of two non-catalytic phospholipases A2-like from Bothrops brazili venom.
Fernandes CA; Comparetti EJ; Borges RJ; Huancahuire-Vega S; Ponce-Soto LA; Marangoni S; Soares AM; Fontes MR
Biochim Biophys Acta; 2013 Dec; 1834(12):2772-81. PubMed ID: 24145104
[TBL] [Abstract][Full Text] [Related]
15. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2.
Pereañez JA; Patiño AC; Núñez V; Osorio E
Chem Biol Interact; 2014 Sep; 220():94-101. PubMed ID: 24995575
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Effects of
Moreira V; Leiguez E; Janovits PM; Maia-Marques R; Fernandes CM; Teixeira C
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941706
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom.
Soares AM; Andrião-Escarso SH; Bortoleto RK; Rodrigues-Simioni L; Arni RK; Ward RJ; Gutiérrez JM; Giglio JR
Arch Biochem Biophys; 2001 Mar; 387(2):188-96. PubMed ID: 11370840
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A
Bryan-Quirós W; Fernández J; Gutiérrez JM; Lewin MR; Lomonte B
Toxicon; 2019 Jan; 157():1-7. PubMed ID: 30447275
[TBL] [Abstract][Full Text] [Related]
19. A SequenceSpace analysis of Lys49 phopholipases A2: clues towards identification of residues involved in a novel mechanism of membrane damage and in myotoxicity.
Ward RJ; Alves AR; Ruggiero Neto J; Arni RK; Casari G
Protein Eng; 1998 Apr; 11(4):285-94. PubMed ID: 9680190
[TBL] [Abstract][Full Text] [Related]
20. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.
Marcussi S; Sant'Ana CD; Oliveira CZ; Rueda AQ; Menaldo DL; Beleboni RO; Stabeli RG; Giglio JR; Fontes MR; Soares AM
Curr Top Med Chem; 2007; 7(8):743-56. PubMed ID: 17456038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
